Some molecular targets for antihyperlipidemic drug research

European Journal of Medicinal Chemistry
2014.0

Abstract

High levels of cholesterol and other lipid constituents are major risk factors in the development of atherosclerosis as well as diseases and disorders associated with it. Though, drugs of various categories acting through different mechanisms are available for antihyperlipidemic therapy, there are limitations associated with each of them, keeping the interest in discovery of newer and better antihyperlipidemic drugs alive. Identification and exploitation of novel molecular targets for discovery of new antihyperlipidemic drugs is an important area of research. Twenty such drug targets are elaborated herein, for their biochemical roles, structures, estimations, as well as, exploitation for new drug discovery research. Few recently discovered drugs are based on such molecular targets are also discussed.

Knowledge Graph

Similar Paper

Some molecular targets for antihyperlipidemic drug research
European Journal of Medicinal Chemistry 2014.0
Lipid lowering agents of natural origin: An account of some promising chemotypes
European Journal of Medicinal Chemistry 2017.0
Discovery and synthesis of novel substituted benzocoumarins as orally active lipid modulating agents
Bioorganic & Medicinal Chemistry Letters 2011.0
Small molecules as inhibitors of PCSK9: Current status and future challenges
European Journal of Medicinal Chemistry 2019.0
Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives
Bioorganic & Medicinal Chemistry Letters 2010.0
Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity
European Journal of Medicinal Chemistry 2017.0
Design of Novel Potent Antihyperlipidemic Agents with Antioxidant/Anti-inflammatory Properties: Exploiting Phenothiazine’s Strong Antioxidant Activity
Journal of Medicinal Chemistry 2014.0
Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential
Journal of Medicinal Chemistry 2022.0
Discovery of 7,9-Disulfatetrahydroberberine as Novel Lipid-Lowering Agents
ACS Omega 2020.0
A Novel Class of Antihyperlipidemic Agents with Low Density Lipoprotein Receptor Up-Regulation via the Adaptor Protein Autosomal Recessive Hypercholesterolemia
Journal of Medicinal Chemistry 2010.0